# pathway_0047: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0047.txt)

**Task:** `pathway`  
**Author key, unchanged:** **D** — Protein modification

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MTALDTDTPTAGRSAPLISPGPVIPPPDFGPLDRAQGWAMTAIITALAAITRFLNLGSPTDAGTPIFDEKHYAPQAWQVLHNDGVEDNPGYGLVVHPPVGKQLIAIGEWLFGYNGLGWRFSGAVCGVIIVMLVTRIARRISRSTLVGAIAGLLIIADGVSFVSSRTALLDVFLVMFAVAAFACLMVDRDQVRERMYHAFLDGRIAETRWGTRLGVRWWRFGAGVLLGLACATKWSGLYFVLFFGVMTLVFDAIARKQYHVPHPWRGMLRRDLGPAAYVFGLIPFAVYLASYAPWFASETAVNRYEVGRSIGPDSILPIPDALRSLWHYTHAAYRFHSNLTNADGNHHPWESKPWTWPMSLRPVLYAIDNQDVPGCGAQSCVKAVMLVGTPAMWFIAVPVLGWALWRTVVRRDWRYGAVLVGYMAGFLPWFADIDRQMYFFYATVMAPFLVLAIALILGDILYKPNQNPERRTLGLLTVCFYVALVITNFAWMYPILTGLPISQTTWNLQIWLPSWR

[Multiple Choices]
A. IMP biosynthesis via de novo pathway
B. ubiquinone biosynthesis. .
C. L-cystathionine from O-succinyl-L-homoserine: step 1/1. .
D. Protein modification
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The supplied sequence exactly matches the UniProt record for a polyprenol-phosphate-mannose–protein mannosyltransferase, whose pathway annotation is “Protein modification; protein glycosylation.” The annotation carries an experimental evidence code and cites a publication, although the underlying experiments were not independently reviewed here.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence’s many hydrophobic regions support that it is a membrane protein, but that general feature does not establish that it modifies proteins by mannosylation or distinguish that function from other membrane-protein functions.


**Missing item-specific fact**

> The protein-specific functional annotation identifying this sequence as a protein O-mannosyltransferase and assigning it to protein modification/protein glycosylation.


**Reason**

> The expected choice is supported by the matched protein annotation, but the sequence and choices alone do not provide a sufficiently specific biological argument for its pathway.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the choices, protein modification is the one consistent with the matched protein’s pathway annotation; the other options name distinct metabolic processes.


### Important caveats

- Reviewer-only accession and database evidence were not supplied to the evaluated model.
- The sequence match establishes source applicability, but the database annotation and its cited experimental evidence are not a substitute for independent evaluation of the primary study.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence’s many hydrophobic regions support that it is a membrane protein, but that general feature does not establish that it modifies proteins by mannosylation or distinguish that function from other membrane-protein functions.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific functional annotation identifying this sequence as a protein O-mannosyltransferase and assigning it to protein modification/protein glycosylation.",
    "reason": "The expected choice is supported by the matched protein annotation, but the sequence and choices alone do not provide a sufficiently specific biological argument for its pathway."
  },
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the UniProt record for a polyprenol-phosphate-mannose–protein mannosyltransferase, whose pathway annotation is “Protein modification; protein glycosylation.” The annotation carries an experimental evidence code and cites a publication, although the underlying experiments were not independently reviewed here."
  },
  "important_caveats": [
    "Reviewer-only accession and database evidence were not supplied to the evaluated model.",
    "The sequence match establishes source applicability, but the database annotation and its cited experimental evidence are not a substitute for independent evaluation of the primary study."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the choices, protein modification is the one consistent with the matched protein’s pathway annotation; the other options name distinct metabolic processes."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the UniProt record for a polyprenol-phosphate-mannose–protein mannosyltransferase, whose pathway annotation is “Protein modification; protein glycosylation.” The annotation carries an experimental evidence code and cites a publication, although the underlying experiments were not independently reviewed here.",
    "evidence_ids": ["C1", "C4", "C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence’s many hydrophobic regions support that it is a membrane protein, but that general feature does not establish that it modifies proteins by mannosylation or distinguish that function from other membrane-protein functions.",
    "missing_item_specific_fact": "The protein-specific functional annotation identifying this sequence as a protein O-mannosyltransferase and assigning it to protein modification/protein glycosylation.",
    "reason": "The expected choice is supported by the matched protein annotation, but the sequence and choices alone do not provide a sufficiently specific biological argument for its pathway."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the choices, protein modification is the one consistent with the matched protein’s pathway annotation; the other options name distinct metabolic processes."
  },
  "important_caveats": [
    "Reviewer-only accession and database evidence were not supplied to the evaluated model.",
    "The sequence match establishes source applicability, but the database annotation and its cited experimental evidence are not a substitute for independent evaluation of the primary study."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry A0R3E8 (sequence matched, 516 AA) annotates the protein as Polyprenol-phosphate-mannose--protein mannosyltransferase (PMT, EC 2.4.1.-) with pathway 'Protein modification; protein glycosylation' backed by experimental evidence (ECO:0000269, PubMed:23550160, PNAS 2013). The expected answer 'Protein modification' directly matches the UniProt pathway annotation.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains approximately 8-10 long hydrophobic stretches consistent with a multi-pass transmembrane architecture. This immediately disfavors options A (IMP de novo biosynthesis, catalyzed by soluble enzymes such as PurA/PurB/PurC) and C (a single-step reaction catalyzed by a soluble cystathionine gamma-synthase-type enzyme). Between B (ubiquinone biosynthesis) and D (protein modification), the multi-pass membrane topology with polar/catalytic loops is characteristic of membrane-anchored glycosyltransferases that transfer sugar moieties from a lipid carrier (polyprenol-phosphate-mannose) to protein substrates, a well-documented class in Actinobacteria including Mycobacterium/Mycolicibacterium. Ubiquinone biosynthesis steps (e.g., UbiA prenyltransferase) involve fewer TM segments and different topology. Thus the membrane architecture provides a meaningful, if not fully definitive, biological argument favoring protein modification over the other three choices.


**Missing item-specific fact**

> Precise identification of the mannosyltransferase catalytic motif (e.g., the DxD motif or polyprenol-phosphate-mannose binding region) would confirm the assignment, but the broad membrane-topology argument is sufficient to distinguish among the four provided options.


**Reason**

> A general biologist can eliminate A and C on the basis that those pathways are catalyzed by soluble enzymes, and can note that the extensive multi-pass membrane architecture in an Actinobacterium is more consistent with a membrane-bound glycosyltransferase (protein modification/glycosylation) than with ubiquinone biosynthesis. The reasoning is not trivial but is grounded in general membrane-protein biology and pathway architecture.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A and C are clearly inconsistent with a multi-pass membrane protein. Option B (ubiquinone biosynthesis) is the closest distractor but involves enzymes with different topology and fewer TM domains. The broad category 'Protein modification' encompasses membrane-bound glycosyltransferases and is the most defensible answer given the sequence features.


### Important caveats

- The UniProt annotation is supported by experimental evidence (PubMed:23550160), not solely computational inference, strengthening the expected answer.
- The reasoning argument (multi-pass membrane → glycosyltransferase) is suggestive but not a unique fingerprint; definitive identification of PMT requires recognizing specific catalytic motifs or database lookup.
- The option 'Protein modification' is very broad and encompasses many sub-pathways; the question relies on it being the only option that fits a membrane-bound glycosyltransferase.
- Reviewer-only evidence (UniProt accession, annotation) was not available to the evaluated model; the assessment of reasoning support is based solely on what a knowledgeable biologist could infer from the sequence and choices.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains approximately 8-10 long hydrophobic stretches consistent with a multi-pass transmembrane architecture. This immediately disfavors options A (IMP de novo biosynthesis, catalyzed by soluble enzymes such as PurA/PurB/PurC) and C (a single-step reaction catalyzed by a soluble cystathionine gamma-synthase-type enzyme). Between B (ubiquinone biosynthesis) and D (protein modification), the multi-pass membrane topology with polar/catalytic loops is characteristic of membrane-anchored glycosyltransferases that transfer sugar moieties from a lipid carrier (polyprenol-phosphate-mannose) to protein substrates, a well-documented class in Actinobacteria including Mycobacterium/Mycolicibacterium. Ubiquinone biosynthesis steps (e.g., UbiA prenyltransferase) involve fewer TM segments and different topology. Thus the membrane architecture provides a meaningful, if not fully definitive, biological argument favoring protein modification over the other three choices.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Precise identification of the mannosyltransferase catalytic motif (e.g., the DxD motif or polyprenol-phosphate-mannose binding region) would confirm the assignment, but the broad membrane-topology argument is sufficient to distinguish among the four provided options.",
    "reason": "A general biologist can eliminate A and C on the basis that those pathways are catalyzed by soluble enzymes, and can note that the extensive multi-pass membrane architecture in an Actinobacterium is more consistent with a membrane-bound glycosyltransferase (protein modification/glycosylation) than with ubiquinone biosynthesis. The reasoning is not trivial but is grounded in general membrane-protein biology and pathway architecture."
  },
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "H1",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry A0R3E8 (sequence matched, 516 AA) annotates the protein as Polyprenol-phosphate-mannose--protein mannosyltransferase (PMT, EC 2.4.1.-) with pathway 'Protein modification; protein glycosylation' backed by experimental evidence (ECO:0000269, PubMed:23550160, PNAS 2013). The expected answer 'Protein modification' directly matches the UniProt pathway annotation."
  },
  "important_caveats": [
    "The UniProt annotation is supported by experimental evidence (PubMed:23550160), not solely computational inference, strengthening the expected answer.",
    "The reasoning argument (multi-pass membrane → glycosyltransferase) is suggestive but not a unique fingerprint; definitive identification of PMT requires recognizing specific catalytic motifs or database lookup.",
    "The option 'Protein modification' is very broad and encompasses many sub-pathways; the question relies on it being the only option that fits a membrane-bound glycosyltransferase.",
    "Reviewer-only evidence (UniProt accession, annotation) was not available to the evaluated model; the assessment of reasoning support is based solely on what a knowledgeable biologist could infer from the sequence and choices."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C are clearly inconsistent with a multi-pass membrane protein. Option B (ubiquinone biosynthesis) is the closest distractor but involves enzymes with different topology and fewer TM domains. The broad category 'Protein modification' encompasses membrane-bound glycosyltransferases and is the most defensible answer given the sequence features."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry A0R3E8 (sequence matched, 516 AA) annotates the protein as Polyprenol-phosphate-mannose--protein mannosyltransferase (PMT, EC 2.4.1.-) with pathway 'Protein modification; protein glycosylation' backed by experimental evidence (ECO:0000269, PubMed:23550160, PNAS 2013). The expected answer 'Protein modification' directly matches the UniProt pathway annotation.",
    "evidence_ids": ["C4", "C5", "C6", "H1", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains approximately 8-10 long hydrophobic stretches consistent with a multi-pass transmembrane architecture. This immediately disfavors options A (IMP de novo biosynthesis, catalyzed by soluble enzymes such as PurA/PurB/PurC) and C (a single-step reaction catalyzed by a soluble cystathionine gamma-synthase-type enzyme). Between B (ubiquinone biosynthesis) and D (protein modification), the multi-pass membrane topology with polar/catalytic loops is characteristic of membrane-anchored glycosyltransferases that transfer sugar moieties from a lipid carrier (polyprenol-phosphate-mannose) to protein substrates, a well-documented class in Actinobacteria including Mycobacterium/Mycolicibacterium. Ubiquinone biosynthesis steps (e.g., UbiA prenyltransferase) involve fewer TM segments and different topology. Thus the membrane architecture provides a meaningful, if not fully definitive, biological argument favoring protein modification over the other three choices.",
    "missing_item_specific_fact": "Precise identification of the mannosyltransferase catalytic motif (e.g., the DxD motif or polyprenol-phosphate-mannose binding region) would confirm the assignment, but the broad membrane-topology argument is sufficient to distinguish among the four provided options.",
    "reason": "A general biologist can eliminate A and C on the basis that those pathways are catalyzed by soluble enzymes, and can note that the extensive multi-pass membrane architecture in an Actinobacterium is more consistent with a membrane-bound glycosyltransferase (protein modification/glycosylation) than with ubiquinone biosynthesis. The reasoning is not trivial but is grounded in general membrane-protein biology and pathway architecture."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and C are clearly inconsistent with a multi-pass membrane protein. Option B (ubiquinone biosynthesis) is the closest distractor but involves enzymes with different topology and fewer TM domains. The broad category 'Protein modification' encompasses membrane-bound glycosyltransferases and is the most defensible answer given the sequence features."
  },
  "important_caveats": [
    "The UniProt annotation is supported by experimental evidence (PubMed:23550160), not solely computational inference, strengthening the expected answer.",
    "The reasoning argument (multi-pass membrane → glycosyltransferase) is suggestive but not a unique fingerprint; definitive identification of PMT requires recognizing specific catalytic motifs or database lookup.",
    "The option 'Protein modification' is very broad and encompasses many sub-pathways; the question relies on it being the only option that fits a membrane-bound glycosyltransferase.",
    "Reviewer-only evidence (UniProt accession, annotation) was not available to the evaluated model; the assessment of reasoning support is based solely on what a knowledgeable biologist could infer from the sequence and choices."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches the annotated protein, whose pathway is listed as protein modification, specifically protein glycosylation. The pathway annotation carries an experimental evidence code, though the underlying study was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is strongly membrane-associated, with many hydrophobic segments, consistent with a membrane glycosyltransferase that modifies proteins. Transferable knowledge of bacterial protein O-mannosyltransferases connects this kind of enzyme to protein glycosylation and thus to option D. The other options name specific small-molecule biosynthetic or conversion pathways and are less consistent with that enzyme-family inference.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Family-level recognition and the sequence's membrane-protein character provide a meaningful basis for distinguishing protein modification from the offered metabolic alternatives. This is a probabilistic inference, not proof of the exact annotation from sequence alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the listed options, protein modification is the defensible pathway category for a protein O-mannosylating enzyme.


### Important caveats

- The pathway annotation is supported by a cited experimental evidence code, but the primary study was not independently assessed.
- The exact protein identity and its database annotation were reviewer-only evidence and are not used as the basis for transferability.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is strongly membrane-associated, with many hydrophobic segments, consistent with a membrane glycosyltransferase that modifies proteins. Transferable knowledge of bacterial protein O-mannosyltransferases connects this kind of enzyme to protein glycosylation and thus to option D. The other options name specific small-molecule biosynthetic or conversion pathways and are less consistent with that enzyme-family inference.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Family-level recognition and the sequence's membrane-protein character provide a meaningful basis for distinguishing protein modification from the offered metabolic alternatives. This is a probabilistic inference, not proof of the exact annotation from sequence alone."
  },
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence matches the annotated protein, whose pathway is listed as protein modification, specifically protein glycosylation. The pathway annotation carries an experimental evidence code, though the underlying study was not independently reviewed here."
  },
  "important_caveats": [
    "The pathway annotation is supported by a cited experimental evidence code, but the primary study was not independently assessed.",
    "The exact protein identity and its database annotation were reviewer-only evidence and are not used as the basis for transferability."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed options, protein modification is the defensible pathway category for a protein O-mannosylating enzyme."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches the annotated protein, whose pathway is listed as protein modification, specifically protein glycosylation. The pathway annotation carries an experimental evidence code, though the underlying study was not independently reviewed here.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is strongly membrane-associated, with many hydrophobic segments, consistent with a membrane glycosyltransferase that modifies proteins. Transferable knowledge of bacterial protein O-mannosyltransferases connects this kind of enzyme to protein glycosylation and thus to option D. The other options name specific small-molecule biosynthetic or conversion pathways and are less consistent with that enzyme-family inference.",
    "missing_item_specific_fact": "",
    "reason": "Family-level recognition and the sequence's membrane-protein character provide a meaningful basis for distinguishing protein modification from the offered metabolic alternatives. This is a probabilistic inference, not proof of the exact annotation from sequence alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the listed options, protein modification is the defensible pathway category for a protein O-mannosylating enzyme."
  },
  "important_caveats": [
    "The pathway annotation is supported by a cited experimental evidence code, but the primary study was not independently assessed.",
    "The exact protein identity and its database annotation were reviewer-only evidence and are not used as the basis for transferability."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry (both current and historical, evidence C5 and H3) annotates the pathway as 'Protein modification; protein glycosylation.' The protein is a polyprenol-phosphate-mannose--protein mannosyltransferase (PMT, EC 2.4.1.-), which catalyzes O-mannosylation of proteins—a protein modification reaction. The author's answer D ('Protein modification') aligns directly with this annotation, which is supported by experimental evidence (PubMed:23550160, ECO:0000269).

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence displays hallmarks of the DUF2666/PMT (polyprenol-phosphate-mannose protein mannosyltransferase) family: (1) an N-terminal signal peptide followed by approximately 8–10 transmembrane helices, consistent with membrane-bound glycosyltransferases; (2) characteristic 'QY' and 'DR' motifs embedded within hydrophobic segments (e.g., '…FDAIARKQY', '…ADIDRQMY…', '…GDILYKPNQNPERR…'), which are signature residues of the DUF2666/PMT domain found across eukaryotic and bacterial PMT homologs; (3) a cytoplasmic loop region with '…PDALRSLWHYTHAAYRFHSN…' resembling the catalytic loop of PMT family members. A model with knowledge of the PMT/DUF2666 family (e.g., eukaryotic PMT1/PMT2, bacterial PmtA) would recognize this multi-pass membrane glycosyltransferase architecture and infer protein O-mannosylation—a protein modification. The distractors are architecturally and mechanistically distinct: IMP biosynthesis (A) involves soluble purine-pathway enzymes; ubiquinone biosynthesis (B) involves prenyltransferases (UbiA-type) and hydroxylases with different domain topologies; cystathionine synthesis (C) is a single-step reaction by a soluble PLP-dependent enzyme. None of these alternatives feature the DUF2666 multi-TM membrane glycosyltransferase architecture.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> Recognition of the DUF2666/PMT domain family and its multi-pass membrane topology is transferable knowledge from well-characterized eukaryotic and bacterial PMT homologs. The distinctive QY/DR motifs within transmembrane segments, combined with the overall membrane architecture, meaningfully distinguish 'Protein modification' (D) from the three soluble or mechanistically unrelated pathway options. This does not require memorizing this exact protein's UniProt record.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options represent clearly distinct biochemical pathways. Option D ('Protein modification') is the broad UniProt pathway category encompassing glycosylation, and the other three options describe specific metabolic steps (purine synthesis, ubiquinone synthesis, amino acid biosynthesis) that are mechanistically and structurally incompatible with a multi-pass membrane DUF2666/PMT glycosyltransferase. No ambiguity in selecting the correct option.


### Important caveats

- The UniProt pathway annotation 'Protein modification; protein glycosylation' is supported by experimental evidence (ECO:0000269, PubMed:23550160), not merely computational inference.
- The DUF2666 domain recognition argument relies on the model's familiarity with the PMT family across organisms; a model lacking this family-level knowledge might struggle with the motif identification.
- Option D uses the broad UniProt pathway category name rather than the specific sub-pathway ('protein glycosylation'), which is acceptable but less precise.
- The reviewer-only evidence confirms sequence match and annotation, but the evaluated model only had the raw sequence and four options.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence displays hallmarks of the DUF2666/PMT (polyprenol-phosphate-mannose protein mannosyltransferase) family: (1) an N-terminal signal peptide followed by approximately 8–10 transmembrane helices, consistent with membrane-bound glycosyltransferases; (2) characteristic 'QY' and 'DR' motifs embedded within hydrophobic segments (e.g., '…FDAIARKQY', '…ADIDRQMY…', '…GDILYKPNQNPERR…'), which are signature residues of the DUF2666/PMT domain found across eukaryotic and bacterial PMT homologs; (3) a cytoplasmic loop region with '…PDALRSLWHYTHAAYRFHSN…' resembling the catalytic loop of PMT family members. A model with knowledge of the PMT/DUF2666 family (e.g., eukaryotic PMT1/PMT2, bacterial PmtA) would recognize this multi-pass membrane glycosyltransferase architecture and infer protein O-mannosylation—a protein modification. The distractors are architecturally and mechanistically distinct: IMP biosynthesis (A) involves soluble purine-pathway enzymes; ubiquinone biosynthesis (B) involves prenyltransferases (UbiA-type) and hydroxylases with different domain topologies; cystathionine synthesis (C) is a single-step reaction by a soluble PLP-dependent enzyme. None of these alternatives feature the DUF2666 multi-TM membrane glycosyltransferase architecture.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "Recognition of the DUF2666/PMT domain family and its multi-pass membrane topology is transferable knowledge from well-characterized eukaryotic and bacterial PMT homologs. The distinctive QY/DR motifs within transmembrane segments, combined with the overall membrane architecture, meaningfully distinguish 'Protein modification' (D) from the three soluble or mechanistically unrelated pathway options. This does not require memorizing this exact protein's UniProt record."
  },
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry (both current and historical, evidence C5 and H3) annotates the pathway as 'Protein modification; protein glycosylation.' The protein is a polyprenol-phosphate-mannose--protein mannosyltransferase (PMT, EC 2.4.1.-), which catalyzes O-mannosylation of proteins—a protein modification reaction. The author's answer D ('Protein modification') aligns directly with this annotation, which is supported by experimental evidence (PubMed:23550160, ECO:0000269)."
  },
  "important_caveats": [
    "The UniProt pathway annotation 'Protein modification; protein glycosylation' is supported by experimental evidence (ECO:0000269, PubMed:23550160), not merely computational inference.",
    "The DUF2666 domain recognition argument relies on the model's familiarity with the PMT family across organisms; a model lacking this family-level knowledge might struggle with the motif identification.",
    "Option D uses the broad UniProt pathway category name rather than the specific sub-pathway ('protein glycosylation'), which is acceptable but less precise.",
    "The reviewer-only evidence confirms sequence match and annotation, but the evaluated model only had the raw sequence and four options."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent clearly distinct biochemical pathways. Option D ('Protein modification') is the broad UniProt pathway category encompassing glycosylation, and the other three options describe specific metabolic steps (purine synthesis, ubiquinone synthesis, amino acid biosynthesis) that are mechanistically and structurally incompatible with a multi-pass membrane DUF2666/PMT glycosyltransferase. No ambiguity in selecting the correct option."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0047",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry (both current and historical, evidence C5 and H3) annotates the pathway as 'Protein modification; protein glycosylation.' The protein is a polyprenol-phosphate-mannose--protein mannosyltransferase (PMT, EC 2.4.1.-), which catalyzes O-mannosylation of proteins—a protein modification reaction. The author's answer D ('Protein modification') aligns directly with this annotation, which is supported by experimental evidence (PubMed:23550160, ECO:0000269).",
    "evidence_ids": ["C5", "H3", "C4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence displays hallmarks of the DUF2666/PMT (polyprenol-phosphate-mannose protein mannosyltransferase) family: (1) an N-terminal signal peptide followed by approximately 8–10 transmembrane helices, consistent with membrane-bound glycosyltransferases; (2) characteristic 'QY' and 'DR' motifs embedded within hydrophobic segments (e.g., '…FDAIARKQY', '…ADIDRQMY…', '…GDILYKPNQNPERR…'), which are signature residues of the DUF2666/PMT domain found across eukaryotic and bacterial PMT homologs; (3) a cytoplasmic loop region with '…PDALRSLWHYTHAAYRFHSN…' resembling the catalytic loop of PMT family members. A model with knowledge of the PMT/DUF2666 family (e.g., eukaryotic PMT1/PMT2, bacterial PmtA) would recognize this multi-pass membrane glycosyltransferase architecture and infer protein O-mannosylation—a protein modification. The distractors are architecturally and mechanistically distinct: IMP biosynthesis (A) involves soluble purine-pathway enzymes; ubiquinone biosynthesis (B) involves prenyltransferases (UbiA-type) and hydroxylases with different domain topologies; cystathionine synthesis (C) is a single-step reaction by a soluble PLP-dependent enzyme. None of these alternatives feature the DUF2666 multi-TM membrane glycosyltransferase architecture.",
    "missing_item_specific_fact": "",
    "reason": "Recognition of the DUF2666/PMT domain family and its multi-pass membrane topology is transferable knowledge from well-characterized eukaryotic and bacterial PMT homologs. The distinctive QY/DR motifs within transmembrane segments, combined with the overall membrane architecture, meaningfully distinguish 'Protein modification' (D) from the three soluble or mechanistically unrelated pathway options. This does not require memorizing this exact protein's UniProt record."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options represent clearly distinct biochemical pathways. Option D ('Protein modification') is the broad UniProt pathway category encompassing glycosylation, and the other three options describe specific metabolic steps (purine synthesis, ubiquinone synthesis, amino acid biosynthesis) that are mechanistically and structurally incompatible with a multi-pass membrane DUF2666/PMT glycosyltransferase. No ambiguity in selecting the correct option."
  },
  "important_caveats": [
    "The UniProt pathway annotation 'Protein modification; protein glycosylation' is supported by experimental evidence (ECO:0000269, PubMed:23550160), not merely computational inference.",
    "The DUF2666 domain recognition argument relies on the model's familiarity with the PMT family across organisms; a model lacking this family-level knowledge might struggle with the motif identification.",
    "Option D uses the broad UniProt pathway category name rather than the specific sub-pathway ('protein glycosylation'), which is acceptable but less precise.",
    "The reviewer-only evidence confirms sequence match and annotation, but the evaluated model only had the raw sequence and four options."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0R3E8",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "283fcdf8941135b9c8b4851bf735e03f92c71bebe99b9f17b27ab97279f6a1a0",
  "benchmark_sequence_length": 516,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 116,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2007-01-09",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44",
  "current_source_sequence_sha256": "283fcdf8941135b9c8b4851bf735e03f92c71bebe99b9f17b27ab97279f6a1a0",
  "current_source_sequence_length": 516,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 114,
  "selected_historical_version": {
    "accession": "A0R3E8",
    "database": "Swiss-Prot",
    "entryVersion": 114,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "PMT_MYCS2",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "4c32d7463b098ec708cba16ef0ffc8465a4a08c5c9abc6fb7d70933bd38435a7",
  "selected_historical_source_sequence_sha256": "283fcdf8941135b9c8b4851bf735e03f92c71bebe99b9f17b27ab97279f6a1a0",
  "selected_historical_source_sequence_length": 516,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 114,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0R3E8.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0R3E8.json",
  "source_sha256": "7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44",
  "retrieved_utc": "2026-11-02T04:26:45.822179+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0R3E8\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0R3E8.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0R3E8.json",
  "source_sha256": "7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44",
  "retrieved_utc": "2026-11-02T04:26:45.822179+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":116,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2007-01-09\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0R3E8.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0R3E8.json",
  "source_sha256": "7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44",
  "retrieved_utc": "2026-11-02T04:26:45.822179+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"commonName\":\"Mycobacterium smegmatis\",\"lineage\":[\"Bacteria\",\"Bacillati\",\"Actinomycetota\",\"Actinomycetes\",\"Mycobacteriales\",\"Mycobacteriaceae\",\"Mycolicibacterium\"],\"scientificName\":\"Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155)\",\"taxonId\":246196}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0R3E8.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0R3E8.json",
  "source_sha256": "7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44",
  "retrieved_utc": "2026-11-02T04:26:45.822179+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"23550160\",\"source\":\"PubMed\"}],\"value\":\"Protein O-mannosyltransferase\"},\"shortNames\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"23550160\",\"source\":\"PubMed\"}],\"value\":\"PMT\"}]}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"23550160\",\"source\":\"PubMed\"}],\"value\":\"2.4.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"Polyprenol-phosphate-mannose--protein mannosyltransferase\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0R3E8.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0R3E8.json",
  "source_sha256": "7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44",
  "retrieved_utc": "2026-11-02T04:26:45.822179+00:00",
  "json_pointer": "/comments/1",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"23550160\",\"source\":\"PubMed\"}],\"value\":\"Protein modification; protein glycosylation\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0R3E8.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0R3E8.json",
  "source_sha256": "7460bfadb65f50b4073bc118af38399e6b1513a5f5a97e209de8bb6435c7ac44",
  "retrieved_utc": "2026-11-02T04:26:45.822179+00:00",
  "json_pointer": "/references/3",
  "excerpt": "{\"citation\":{\"authors\":[\"Liu C.F.\",\"Tonini L.\",\"Malaga W.\",\"Beau M.\",\"Stella A.\",\"Bouyssie D.\",\"Jackson M.C.\",\"Nigou J.\",\"Puzo G.\",\"Guilhot C.\",\"Burlet-Schiltz O.\",\"Riviere M.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"23550160\"},{\"database\":\"DOI\",\"id\":\"10.1073/pnas.1219704110\"}],\"citationType\":\"journal article\",\"firstPage\":\"6560\",\"id\":\"23550160\",\"journal\":\"Proc. Natl. Acad. Sci. U.S.A.\",\"lastPage\":\"6565\",\"publicationDate\":\"2013\",\"title\":\"Bacterial protein-O-mannosylating enzyme is crucial for virulence of Mycobacterium tuberculosis.\",\"volume\":\"110\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"ATCC 700084 / mc(2)155\"}],\"referenceNumber\":4,\"referencePositions\":[\"FUNCTION\",\"PATHWAY\",\"DISRUPTION PHENOTYPE\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0R3E8?format=txt&versions=114)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0R3E8?format=txt&versions=114",
  "source_sha256": "4c32d7463b098ec708cba16ef0ffc8465a4a08c5c9abc6fb7d70933bd38435a7",
  "retrieved_utc": "2026-11-02T04:26:48.840229+00:00",
  "source_locator": "lines 1-16",
  "excerpt": "ID   PMT_MYCS2               Reviewed;         516 AA.\nAC   A0R3E8; I7GFC3;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   09-JAN-2007, sequence version 1.\nDT   28-JAN-2026, entry version 114.\nDE   RecName: Full=Polyprenol-phosphate-mannose--protein mannosyltransferase {ECO:0000305};\nDE            EC=2.4.1.- {ECO:0000305|PubMed:23550160};\nDE   AltName: Full=Protein O-mannosyltransferase {ECO:0000303|PubMed:23550160};\nDE            Short=PMT {ECO:0000303|PubMed:23550160};\nGN   OrderedLocusNames=MSMEG_5447 {ECO:0000312|EMBL:ABK72177.1},\nGN   MSMEI_5297 {ECO:0000312|EMBL:AFP41739.1};\nOS   Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) (Mycobacterium\nOS   smegmatis).\nOC   Bacteria; Bacillati; Actinomycetota; Actinomycetes; Mycobacteriales;\nOC   Mycobacteriaceae; Mycolicibacterium.\nOX   NCBI_TaxID=246196;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 114,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0R3E8?format=txt&versions=114)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0R3E8?format=txt&versions=114",
  "source_sha256": "4c32d7463b098ec708cba16ef0ffc8465a4a08c5c9abc6fb7d70933bd38435a7",
  "retrieved_utc": "2026-11-02T04:26:48.840229+00:00",
  "source_locator": "lines 41-49",
  "excerpt": "RN   [4]\nRP   FUNCTION, PATHWAY, AND DISRUPTION PHENOTYPE.\nRC   STRAIN=ATCC 700084 / mc(2)155;\nRX   PubMed=23550160; DOI=10.1073/pnas.1219704110;\nRA   Liu C.F., Tonini L., Malaga W., Beau M., Stella A., Bouyssie D.,\nRA   Jackson M.C., Nigou J., Puzo G., Guilhot C., Burlet-Schiltz O., Riviere M.;\nRT   \"Bacterial protein-O-mannosylating enzyme is crucial for virulence of\nRT   Mycobacterium tuberculosis.\";\nRL   Proc. Natl. Acad. Sci. U.S.A. 110:6560-6565(2013).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 114,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0R3E8?format=txt&versions=114)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0R3E8?format=txt&versions=114",
  "source_sha256": "4c32d7463b098ec708cba16ef0ffc8465a4a08c5c9abc6fb7d70933bd38435a7",
  "retrieved_utc": "2026-11-02T04:26:48.840229+00:00",
  "source_locator": "lines 54-55",
  "excerpt": "CC   -!- PATHWAY: Protein modification; protein glycosylation.\nCC       {ECO:0000269|PubMed:23550160}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 114,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 47. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
